Having cosmetics products manufactured from 1,000 units: When small batches make sense
Having cosmetics products manufactured from 1,000 units: When small batches make sense
12 min read
CEO & Founder at Labtree GmbH
Small batches starting from 1,000 units are not second rate—they are a strategic lever for brands wanting to validate the market before investing in larger volumes.
The topic is short and compact
Small batches from 1,000 units are a strategic lever for market testing, trend launches, and drugstore pitches.
unit costs 1.5 to 2 times higher than industrial production, but significantly lower risk.
Requirements: test batch capability, formulations with low minimum quantities, clear scaling path.
Proof of Concept: Test a new product category before investing in full market preparation
Trend-driven products: Rapid response to market trends with limited risk
Influencer launches: Initial reach with a manageable initial investment
Drugstore pitches: Small batches for pitches and listing negotiations before investing in industrial volumes
Seasonal products: Special editions or limited releases
New markets: Geographical or demographic market tests
When small batches make strategic sense
Proof of Concept: Test a new product category before investing in full market preparation
Trend-driven products: Rapid response to market trends with limited risk
Influencer launches: Initial reach with a manageable initial investment
Drugstore pitches: Small batches for pitches and listing negotiations before investing in industrial volumes
Seasonal products: Special editions or limited releases
New markets: Geographical or demographic market tests
unit costs in small batches
unit costs for 1,000–2,000 units are typically 1.5 to 2 times higher than industrial production at 10,000+ units. Reasons:
Setup costs of the filling line are distributed over fewer units
Packaging MOQs can be higher than the product batch
Quality control effort remains fixed, therefore proportionally higher
These additional costs are the 'insurance against wrong decisions'; if the product fails in the market, the financial loss is significantly smaller than with an industrial batch.
Manufacturer prerequisites
Test-batch capability: Mixers and filling systems must be able to produce small batches in a technically clean manner
Formulations with low minimum quantities: Some carrier systems require higher minimum quantities, a relevant selection for the formulation base
Packaging strategy: Standard packaging with available inventory avoids the MOQs of packaging suppliers
Scaling path: If the market test is positive, the manufacturer must be able to scale quickly to industrial batches
Practical Example: Skincare Series as Proof of Concept
A supplement brand wanted to launch a skincare line in addition. Strategy: First proof of concept with small batches, then scaling upon market success.
Specifically: Ten products in small batches of approx. 2,000 units per product including packaging. After a successful PoC and winning the pitch, scaling was implemented within three months, securing placement in drugstores.
What characterized this case: The products were not developed in isolation but considered as a complete, launch-ready series, including raw materials, packaging, production, documentation, and regulatory approval data.
What to consider during planning
Realistic sales expectation: How quickly is the batch sold? Standstill costs money (shelf life, storage costs)
Readiness to scale: In case of success, the next batch must follow without delay, raw materials, packaging, production slot
Market test methodology: How is success measured? Sales figures, reach, retail feedback, consumer tests?
Documentation: Even for small batches, PIF and CPNP must be correct
In-depth sources: The legal basis for all cosmetic products marketed in the EU is the EU Cosmetics Regulation (EC) No. 1223/2009. The health assessment of ingredients in Germany lies with the Federal Institute for Risk Assessment (BfR). Industry information and market data are published by the German Cosmetic, Toiletry, Perfumery and Detergent Association (IKW).
Conclusion
Having cosmetic products manufactured from 1,000 units is a strategic option, not a makeshift solution. Higher unit costs are the insurance against wrong decisions in the event of an uncertain market launch. The prerequisite is a manufacturer with test-batch capacities, formulations with low minimum quantities, and a clear scaling path.
Related articles: MOQ in cosmetics · Having cosmetics manufactured · Costs of cosmetics production
More useful links
FAQ
Does Labtree have its own laboratory?
Yes. Labtree has its own development expertise, including a laboratory. This means that formulations can not only be selected, but specifically developed, tested, and adjusted. Additionally, smaller test batches can be produced in-house in order to validate products early on in real conditions and safely transfer them to production.
How much does a batch of 1,000 pieces cost?
Project-dependent. Unit costs are typically 1.5 to 2 times higher than in industrial production. A concrete calculation depends on the formulation, packaging, and product category.
Are small batches qualitatively equivalent to industrial batches?
Yes, provided the manufacturer complies with the technical minimum quantities. Small batches from test batch production are qualitatively identical to larger batches, the difference lies only in the cost-efficiency per unit.
How quickly can I scale up to industrial batches?
Realistic within three months with integrated partners and when production readiness is prepared. Prerequisite: raw materials available, packaging deliverable, regulatory documentation complete.
Which packaging is suitable for small batches?
Standard packaging that the manufacturer already has in stock. Custom packaging often has its own MOQs, which are well over 1,000 units; they are a poor fit for test batches.
Are small batches economically viable?
In a narrower sense usually not, as the unit margin is lower than with industrial batches. But as risk management before a major investment, they are almost always strategically worthwhile.
Now discover more articles
